Cannabidiol gel ZYN002 for fragile X fails to meet goal in trial: Data
Use of CBD gel ZYN002 showed no greater effects vs. a placebo on social avoidance behavior in young people with fragile X syndrome in trial.| Fragile X News Today
Use of CBD gel ZYN002 showed no greater effects vs. a placebo on social avoidance behavior in young people with fragile X syndrome in trial.| Fragile X News Today
Treatment with esketamine, a compound related to ketamine, led to some behavioral improvements in three girls with Rett syndrome in a trial.| Rett Syndrome News
